AlphaFold predicted structure
SLC32A1 · Q9H598

Mean pLDDT
78.1/ 100
Confident
525 residues
Confidence breakdown
- Very high(≥ 90)49%
- Confident(70–90)24%
- Low(50–70)7%
- Very low(< 50)20%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
solute carrier family 32 member 1
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownEarly onset or syndromic epilepsy
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedIntellectual disability
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinteddevelopmental and epileptic encephalopathy 114
generalized epilepsy with febrile seizures plus, type 12
generalized epilepsy with febrile seizures plus
early-infantile DEE
Generalized epilepsy with febrile seizures-plus
Intellectual disability
Seizure
restless legs syndrome
neurodegenerative disease
autoimmune disorder of central nervous system
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Vesicular inhibitory amino acid transporter
Antiporter that exchanges vesicular protons for cytosolic 4-aminobutanoate or to a lesser extend glycine, thus allowing their secretion from nerve terminals. The transport is equally dependent on the chemical and electrical components of the proton gradient (By similarity). May also transport beta-alanine (By similarity). Acidification of GABAergic synaptic vesicles is a prerequisite for 4-aminobutanoate uptake (By similarity)
SLC32A1 · Q9H598

Mean pLDDT
78.1/ 100
Confident
525 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0